Cherubism: Best clinical practice

Orphanet Journal of Rare Diseases

Volumn 7, Issue SUPPL. 1, 2012, Pages

  Papadaki, Maria E ^a   Lietman, Steven A ^b   Levine, Michael A ^c   Olsen, Bjorn R ^d   Kaban, Leonard B ^a   Reichenberger, Ernst J ^e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; HEMOSIDERIN; HYDROXYPROLINE; PARATHYROID HORMONE RELATED PROTEIN; PYRIDINIUM DERIVATIVE; BIOLOGICAL MARKER; SH3BP2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

AIRWAY OBSTRUCTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPIRATION; BONE MATRIX; BONE REMODELING; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CERVICAL LYMPH NODE; CLINICAL FEATURE; CLINICAL PRACTICE; CLUBBING FINGERS; CONFERENCE PAPER; CORTICAL BONE; CRANIOFACIAL SYNOSTOSIS; CREATININE URINE LEVEL; CURETTAGE; DISEASE SEVERITY; ESTHETIC SURGERY; ESTHETICS; FACE MALFORMATION; FIBROUS DYSPLASIA; GAZE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HISTOLOGY; HUMAN; JAW MALFORMATION; LUNG INFECTION; LYMPHADENOPATHY; MANDIBLE; MAXILLA; MOLAR TOOTH; NOONAN SYNDROME; NOSE INFECTION; NOSE OBSTRUCTION; OSTEOCLAST; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PROGNOSIS; QUALITY OF LIFE; SEPTICEMIA; SLEEP APNEA SYNDROME; SNORING; SWELLING; TONGUE DISEASE; TOOTH EXTRACTION; TOOTH MALFORMATION; TOOTH PROSTHESIS; VISUAL IMPAIRMENT; DIFFERENTIAL DIAGNOSIS; GENETICS; HOSPITALIZATION; JAW; LYMPH NODE; METABOLISM; MUTATION; PATHOLOGY; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BIOLOGICAL MARKERS; CHERUBISM; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; GENETIC TESTING; HUMANS; JAW; LYMPH NODES; MUTATION; NOONAN SYNDROME; SEVERITY OF ILLNESS INDEX;

EID: 84861350007     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-7-S1-S6     Document Type: Conference Paper

References (97)

1. Familial multilocular cystic disease of the jaws. Jones WA, American Journal of Cancer 1933 17 946 950
2. Further observations regarding familal multilocular cystic disease of the jaws. Jones WA, British Journal of Radiology 1938 11 227 241 10.1259/0007-1285-11-124-227
3. Cherubism - familial fibrous dysplasia of the jaws. Jones WA, Gerrie J, Pritchard J, Journal of Bone and Joint Surgery. British Volume 1950 32-B 3 334 47
4. Cherubism - an initial unilateral presentation. Arnott DG, British Journal of Oral Surgery 1978 16 1 38 46 10.1016/S0007-117X(78)80054-7 280369 (Pubitemid 9087793)
5. Cherubism. Seward GR, Hankey GT, Oral Surg Oral Med Oral Pathol 1957 10 9 952 74 10.1016/S0030-4220(57)80047-4 13465106
6. Treatment of cherubism with locally aggressive behavior presenting in adulthood: report of four cases and a proposed new grading system. Kalantar Motamedi MH, Journal of Oral & Maxillofacial Surgery 1998 56 11 1336 42 10.1016/S0278-2391(98)90618-8 9820222
7. Two-stage surgical treatment of severe cherubism. Raposo-Amaral CE, et al. Annals of Plastic Surgery 2007 58 6 645 51 10.1097/01.sap.0000248141.36904. 19 17522488 (Pubitemid 46816802)
8. Cherubism-hereditary fibrous dysplasia of the jaws. I. Genetic considerations. Anderson DE, McClendon JL, Oral Surgery Oral Medicine Oral Pathology 1962 15 Supplement 5 16
9. The role of SH3BP2 in the pathophysiology of cherubism. Reichenberger EJ, et al. Orphanet Journal of Rare Diseases 2012 7 Suppl 1 5
10. Cherubism: familial fibrous dysplasia of the jaws. Thompson N, British Journal of Plastic Surgery 1959 12 89 103
11. Cherubism - clinical picture and treatment. Kozakiewicz M, Perczynska-Partyka W, Kobos J, Oral Dis 2001 7 2 123 30 11355438 (Pubitemid 32318830)
12. Postpubertal nonfamilial cherubism and teeth transposition. Ozan B, et al. Journal of Craniofacial Surgery 2010 21 5 1575 7 10.1097/SCS. 0b013e3181ecc529 20856051
13. Cherubism: a report on three cases. Wayman JB, British Journal of Oral Surgery 1978 16 1 47 56 10.1016/S0007-117X(78)80055-9 280370
14. Cherubism-hereditary fobrous dysplasia of the jaws: II. Pathologic considerations. McClendon JL, Anderson DE, Cornelius EA, Oral Surgery Oral Medicine Oral Pathology 1962 15 Supplement 17 38
15. Craniosynostosis in cherubism. Stiller M, et al. Am J Med Genet 2000 95 4 325 31 10.1002/1096-8628(20001211)95:4<325::AID-AJMG6>3.0.CO;2-R 11186885
16. [Clinical and molecular genetic observations on families with cherubism over three generations]. Petschler M, et al. Mund Kiefer Gesichtschir 2003 7 2 83 7 10.1007/s10006-002-0444-x 12664252
17. Aggressive form of cherubism: report of a case. Timoca GC, et al. Journal of Oral & Maxillofacial Surgery 2000 58 3 336 44 10.1016/S0278-2391(00) 90069-7 10716121
18. Orbital involvement in cherubism. Colombo F, et al. Ophthalmology 2001 108 10 1884 8 10.1016/S0161-6420(01)00757-6 11581066 (Pubitemid 32910244)
19. Giant cell reparative granuloma of the orbit associated with cherubism. Font RL, et al. Ophthalmology 2003 110 9 1846 9 10.1016/S0161-6420(03)00577-3 13129888 (Pubitemid 37025449)
20. Optic neuropathy and macular chorioretinal folds caused by orbital cherubism. Ahmadi AJ, Pirinjian GE, Sires BS, Archives of Ophthalmology 2003 121 4 570 3 10.1001/archopht.121.4.570 12695257 (Pubitemid 36427647)
21. Sleep disordered breathing in an adult with cherubism. Ladhani S, Sundaram P, Joshi JM, Thorax 2003 58 6 552 10.1136/thorax.58.6.552 12775879
22. Cherubism and upper airway obstruction. Battaglia A, Merati A, Magit A, Otolaryngology-Head & Neck Surgery 2000 122 4 573 4 10.1016/S0194-5998(00) 70104-5 10740181 (Pubitemid 30210677)
23. An extreme case of cherubism. Silva EC, et al. Br J Oral Maxillofac Surg 2002 40 1 45 8 10.1054/bjom.2001.0654 11883969 (Pubitemid 34257282)
24. Cherubism involving a mother and daughter: case reports and review of the literature. Faircloth WJ Jr., Edwards RC, Farhood VW, J Oral Maxillofac Surg 1991 49 5 535 42 10.1016/0278-2391(91)90185-O 2019904
25. Aggressive case of cherubism: 17-year follow-up. Pontes FS, et al. Int J Pediatr Otorhinolaryngol 2007 71 5 831 5 10.1016/j.ijporl.2007.01.017 17360048 (Pubitemid 46601611)
26. Cherubism: a report of a case with an unusual post-extraction complication. Ireland AJ, Eveson JW, British Dental Journal 1988 164 4 116 7 10.1038/sj.bdj.4806369 3162374
27. Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature. Von Wowern N, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 90 6 765 72 10.1067/moe.2000.108438 11113824
28. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. Ueki Y, et al. Cell 2007 128 1 71 83 10.1016/j.cell.2006.10.047 17218256 (Pubitemid 46048888)
29. Autoinflammatory bone disorders. Ferguson PJ, El-Shanti HI, Curr Opin Rheumatol 2007 19 5 492 8 10.1097/BOR.0b013e32825f5492 17762617 (Pubitemid 47344244)
30. 3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation. de la Fuente MA, et al. Mol Cell Biol 2006 26 14 5214 25 10.1128/MCB.00087-06 16809760 (Pubitemid 44036193)
31. The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response. Chen G, et al. Mol Cell Biol 2007 27 8 3109 22 10.1128/MCB.01014-06 17283041 (Pubitemid 46581322)
32. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Foucault I, et al. Blood 2005 105 3 1106 13 15345594 (Pubitemid 40170882)
33. The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function. Foucault I, et al. J Biol Chem 2003 278 9 7146 53 10.1074/jbc.M209509200 12501243 (Pubitemid 36800713)
34. Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. Jevremovic D, et al. J Immunol 2001 166 12 7219 28 11390470 (Pubitemid 32525595)
35. Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase. Maeno K, et al. J Biol Chem 2003 278 27 24912 20 10.1074/jbc.M301201200 12709437 (Pubitemid 37548651)
36. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. Lietman SA, et al. Hum Mutat 2006 27 7 717 8 16786512
37. Study of the cell biology and biochemistry of cherubism. Southgate J, et al. Journal of Clinical Pathology 1998 51 11 831 7 10.1136/jcp.51.11.831 10193324 (Pubitemid 28530846)
38. Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature. Ozkan Y, et al. Int J Pediatr Otorhinolaryngol 2003 67 9 1005 12 10.1016/S0165-5876(03)00179-4 12907058 (Pubitemid 36952390)
39. Malignant mesenchymal tumor arising from cherubism: a case report. Shah N, Handa KK, Sharma MC, Journal of Oral & Maxillofacial Surgery 2004 62 6 744 9 10.1016/j.joms.2003.12.015 15170291 (Pubitemid 38736451)
40. Familial cherubism: the experience of the Moscow Central Institute for Stomatology and Maxillo-Facial Surgery. Roginsky VV, et al. International Journal of Oral & Maxillofacial Surgery 2009 38 3 218 23 10.1016/j.ijom.2008.10.010 19038533
41. Clinicopathologic study of 24 cases of cherubism. Meng XM, Yu SF, Yu GY, International Journal of Oral & Maxillofacial Surgery 2005 34 4 350 6 10.1016/j.ijom.2004.09.006 16053841 (Pubitemid 40631346)
42. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Carpten JD, et al. Nat Genet 2002 32 4 676 80 10.1038/ng1048 12434154 (Pubitemid 35435184)
43. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Yart A, et al. Mol Cell Biol 2005 25 12 5052 60 10.1128/MCB.25.12.5052-5060.2005 15923622 (Pubitemid 40781105)
44. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Woodard GE, et al. Oncogene 2005 24 7 1272 6 10.1038/sj.onc.1208274 15580289 (Pubitemid 40313928)
45. Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors. Wang C, et al. Oncology Reports 2006 15 3 589 94 16465417
46. Cherubism. Histo-enzymological and ultrastructural study. Chomette G, et al. International Journal of Oral & Maxillofacial Surgery 1988 17 4 219 23 10.1016/S0901-5027(88)80043-2 3139789
47. Cherubism: a clinical, radiographic, and histopathologic comparison of 7 cases. Pẽarrocha M, et al. Journal of Oral & Maxillofacial Surgery 2006 64 6 924 30 10.1016/j.joms.2006.02.003 16713807 (Pubitemid 43728139)
48. Fine-needle aspiration cytological features of Cherubism. Jing X, Pu RT, Diagnostic Cytopathology 2008 36 3 188 9 10.1002/dc.20791 18232001 (Pubitemid 351312137)
49. Fine needle aspiration cytologic features of Cherubism: a case report. Gupta N, et al. Acta Cytologica 2010 54 4 595 7 20715662
50. Orbital involvement in cherubism. Carroll AL, Sullivan TJ, Clin Experiment Ophthalmol 2001 29 1 38 40 10.1046/j.1442-9071.2001.00363.x 11272784 (Pubitemid 32170796)
51. Aggressive behaviour of cherubism in a teenager: 4-years of clinical follow-up associated with radiographic and histological features. Gomes MF, et al. Dentomaxillofac Radiol 2005 34 5 313 8 10.1259/dmfr/32866350 16120883 (Pubitemid 41329362)
52. The aggressive form of cherubism: report of two cases in unrelated families. Wang CN, et al. British Journal of Oral & Maxillofacial Surgery 2006 44 4 322 4 10.1016/j.bjoms.2005.10.003 16310907 (Pubitemid 43923730)
53. Cherubism and its charlatans. Lannon DA, Earley MJ, Br J Plast Surg 2001 54 8 708 11 10.1054/bjps.2001.3701 11728115 (Pubitemid 33150035)
54. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Ueki Y, et al. Nat Genet 2001 28 2 125 6 10.1038/88832 11381256 (Pubitemid 32538054)
55. Treatment of fibrous dysplasia of the mandible with radical excision and immediate reconstruction: case report. Zenn MR, Zuniga J, Journal of Craniofacial Surgery 2001 12 3 259 63 10.1097/00001665-200105000-00012 11358100 (Pubitemid 34873890)
56. Noonan syndrome with giant cell lesions. Lee SM, Cooper JC, International Journal of Paediatric Dentistry 2005 15 2 140 5 10.1111/j.1365-263X.2005.00604. x 15790374 (Pubitemid 40469996)
57. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism. Jafarov T, Ferimazova N, Reichenberger E, Clin Genet 2005 68 2 190 1 15996221 (Pubitemid 40990635)
58. Noonan syndrome: clinical aspects and molecular pathogenesis. Tartaglia M, Zampino G, Gelb BD, Mol Syndromol 2010 1 1 2 26 10.1159/000276766 20648242
59. Associated noncardiac malformations in children with congenital heart disease. Noonan J, Ehmke D, J Pediatr 1963 63 468 470
60. Central giant cell lesions of the jaws: a clinicopathologic study. Chuong R, et al. Journal of Oral & Maxillofacial Surgery 1986 44 9 708 13 10.1016/0278-2391(86)90040-6 3462363 (Pubitemid 16054060)
61. The Noonan syndrome/cherubism association. Dunlap C, et al. Oral Surgery, Oral Medicine, Oral Pathology 1989 67 6 698 705 10.1016/0030-4220(89)90012-1 (Pubitemid 19163765)
62. Noonan-like/multiple giant cell lesion syndrome. Cohen MM Jr., Gorlin RJ, Am J Med Genet 1991 40 2 159 66 10.1002/ajmg.1320400208 1897569
63. Cherubism in a patient with Noonan syndrome: report of a case. Levine B, Skope L, Parker R, Journal of Oral & Maxillofacial Surgery 1991 49 9 1014 8 10.1016/0278-2391(91)90069-X 1886012
64. Multiple central giant cell lesions with a Noonan-like phenotype. Betts NJ, et al. Oral Surgery, Oral Medicine, Oral Pathology 1993 76 5 601 7 10.1016/0030-4220(93)90069-G (Pubitemid 23347013)
65. Cherubism in a patient with Noonan's syndrome. Addante RR, Breen GH, Journal of Oral & Maxillofacial Surgery 1996 54 2 210 3 10.1016/S0278- 2391(96)90449-8 8604072 (Pubitemid 26046071)
66. Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome. Lee JS, et al. J Med Genet 2005 42 2 11 10.1136/jmg.2004.024091 15689434
67. SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions. Beneteau C, et al. Eur J Hum Genet 2009 17 10 1216 21 10.1038/ejhg.2009.44 19352411
68. Neurofibromatosis presenting with a cherubism phenotype. van Capelle CI, et al. European Journal of Pediatrics 2007 166 9 905 9 10.1007/s00431-006-0334-6 17120035 (Pubitemid 47101340)
69. Bilateral central giant cell granulomas of the mandible in an 8-year-old girl with Noonan syndrome (Noonan-like/multiple giant cell lesion syndrome). Edwards PC, et al. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics 2005 99 3 334 40 10.1016/j.tripleo.2004.08.021 15716842 (Pubitemid 40260653)
70. Spontaneous deletion in the FMR1 gene in a patient with fragile X syndrome and cherubism. Quan F, et al. Human Molecular Genetics 1995 4 9 1681 4 10.1093/hmg/4.9.1681 8541863
71. Gingival fibromatosis combined with cherubism and psychomotor retardation: a rare syndrome. Yalcin S, et al. Journal of Periodontology 1999 70 2 201 4 10.1902/jop.1999.70.2.201 10102559
72. Unusual form of recurrent giant cell granuloma of the mandible and lower extremities in a patient with neurofibromatosis type 1. Ruggieri M, et al. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics 1999 87 1 67 72 10.1016/S1079-2104(99)70297-0 9927083
73. Cherubism, gingival fibromatosis, epilepsy, and mental deficiency (Ramon syndrome) with juvenile rheumatoid arthritis. Pina-Neto JM, et al. American Journal of Medical Genetics 1986 25 3 433 41 10.1002/ajmg.1320250305 3789007 (Pubitemid 16008365)
74. Cherubism combined with epilepsy, mental retardation and gingival fibromatosis (Ramon syndrome): a case report. Suhanya J, et al. Head Neck Pathol 2010 4 2 126 31 10.1007/s12105-009-0155-9 20512637
75. Multiple non-ossifying fibromata with extraskeletal anomalies: a new syndrome? Campanacci M, Laus M, Boriani S, J Bone Joint Surg Br 1983 65 5 627 32 6643569 (Pubitemid 14231207)
76. Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review. Mankin HJ, et al. Chirurgia Degli Organi di Movimento 2009 93 1 1 7 19711155
77. Jaffe-Campanacci syndrome. A case report and review of the literature. Hau MA, et al. J Bone Joint Surg Am 2002 84-A 4 634 8 11940628
78. The gene for cherubism maps to chromosome 4p16. Tiziani V, et al. Am J Hum Genet 1999 65 1 158 66 10.1086/302456 10364528 (Pubitemid 30470460)
79. The gene for cherubism maps to chromosome 4p16.3. Mangion J, et al. American Journal of Human Genetics 1999 65 1 151 7 10.1086/302454 10364527 (Pubitemid 30470459)
80. Identical Mutation in SH3BP2 Gene Causes Clinical Phenotypes with Different Severity in Mother and Daughter-Case Report. Preda L, et al. Mol Syndromol 2010 1 2 87 90 10.1159/000314268 21045962
81. Staged protocol for resection, skeletal reconstruction, and oral rehabilitation of children with jaw tumors. Troulis MJ, Williams WB, Kaban LB, Journal of Oral & Maxillofacial Surgery 2004 62 3 335 43 10.1016/j.joms.2003.07.006 15015167 (Pubitemid 38298533)
82. Cherubism: report of a case showing regression without treatment. Katz JO, Dunlap CL, Ennis RL, Journal of Oral & Maxillofacial Surgery 1992 50 3 301 3 10.1016/0278-2391(92)90333-U 1542075
83. Advances in diagnosis and management of fibro-osseous lesions. Papadaki ME, Troulis MJ, Kaban LB, Oral Maxillofac Surg Clin North Am 2005 17 4 415 34 10.1016/j.coms.2005.06.004 18088796 (Pubitemid 41700028)
84. Vascular transformation in cherubism. Koury ME, Stella JP, Epker BN, Oral Surgery, Oral Medicine, Oral Pathology 1993 76 1 20 7 10.1016/0030-4220(93) 90287-E 7688886 (Pubitemid 23239297)
85. Treatment of mandibular cherubism. Kuepper RC, Harrigan WF, Journal of Oral Surgery 1978 36 8 638 41 277660 (Pubitemid 8403450)
86. Cherubism: report of case. Dukart RC, et al. Journal of Oral Surgery 1974 32 10 782 5 4528468
87. Central giant cell granulomas of the jaws regress with calcitonin therapy. Harris M, British Journal of Oral & Maxillofacial Surgery 1993 31 2 89 94 10.1016/0266-4356(93)90168-V 8471587 (Pubitemid 23119990)
88. A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism. de Lange J, et al. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics 2007 103 3 378 81 10.1016/j.tripleo.2006.05.012 17321449
89. Management of giant cell lesions. Kaban LB, Dodson TB, International Journal of Oral & Maxillofacial Surgery 2006 35 11 1074 5 author reply 1076 10.1016/j.ijom.2006.08.010 17055701 (Pubitemid 44615446)
90. Calcitonin therapy for central giant cell granuloma. Pogrel MA, Journal of Oral & Maxillofacial Surgery 2003 61 6 649 53 discussion 53-4 10.1053/joms.2003.50129 12796868 (Pubitemid 36644846)
91. Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Kaban LB, et al. Pediatrics 1999 103 6 Pt 1 1145 9 10353921 (Pubitemid 29258785)
92. Cherubism: Clinicoradiographic features, treatment, and long-term follow-up of 8 cases. Silva EC, Silva GCC, Vieira TC, Journal of Oral and Maxillofacial Surgery 2007 65 3 517 522 10.1016/j.joms.2006.05.061 17307601 (Pubitemid 46329233)
93. TNFalpha blockade in human diseases: an overview of efficacy and safety. Lin J, et al. Clinical Immunology 2008 126 1 13 30 10.1016/j.clim.2007.08.012 17916445 (Pubitemid 350266448)
94. TNFalpha blockade in human diseases: mechanisms and future directions. Wong M, et al. Clinical Immunology 2008 126 2 121 36 10.1016/j.clim.2007.08.013 17916444
95. Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism. Pagnini I, et al. Clinical and Experimental Rheumatology 2011 29 1 147 21345303
96. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. Aliprantis AO, et al. J Clin Invest 2008 118 11 3775 89 10.1172/JCI35711 18846253
97. Mechanism of inflammation in cherubism. Ueki Y, Mukai T, Yoshitaka T, J Bone Miner Res 2010 25 Suppl 1 Available at [ http://www.asbmr.org/Meetings/ AnnualMeeting/AbstractDetail.aspx?aid=9553097c-08c8-4d7e-897a-6ed4927d0475 ]. Accessed [12-24-2010]